Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Taka Matsumura
Observed name:
Matsumura, Taka
Institution:
Eli Lilly (Japan)
Observed institutions:
Eli Lilly (Japan),
Janssen Pharmaceutical K.K. (Japan)
OpenAlex ID:
A5113915766
Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain
2013
·
Keiichiro Imanaka
, Yushin Tominaga
, et al.
·
Current Medical Research and Opinion
·
79
Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release
2014
·
Keiichiro Imanaka
, Yushin Tominaga
, et al.
·
Clinical Drug Investigation
·
50
PDF
Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
2013
·
Nagahide Takahashi
, Masayoshi Takahashi
, et al.
·
Neuropsychiatric Disease and Treatment
·
33
PDF
A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan
2014
·
Nagahide Takahashi
, Tadaishi Koh
, et al.
·
The World Journal of Biological Psychiatry
·
28
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial
2022
·
Hisaka Igarashi
, Mamoru Shibata
, et al.
·
Neurology and Therapy
·
16
PDF
Costs and resource use of community-dwelling patients with Alzheimer’s disease in Japan: 18-month results from the GERAS-J study
2021
·
Miharu Nakanishi
, Ataru Igarashi
, et al.
·
Current Medical Research and Opinion
·
16
PDF
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
2021
·
Hisaka Igarashi
, Mamoru Shibata
, et al.
·
Journal of Pain Research
·
10
PDF
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
2021
·
Yoshihisa Tatsuoka
, Takao Takeshima
, et al.
·
Neurology and Therapy
·
8
PDF
A Long-Term, Open-Label Study of Paliperidone Palmitate in Patients with Schizophrenia
2013
·
Nagahide Takahashi
, Masayoshi Takahashi
, et al.
·
Progress in medicine
·
3
Disease‐modifying effect of solanezumab evaluated by delayed‐start analysis in a Japanese subpopulation with mild Alzheimer's disease
2017
·
Tomomi Nakamura
, Shinji Fujikoshi
, et al.
·
Neurology and Clinical Neuroscience
·
2
[Safety and Effectiveness of NEPTIS Plug-01 and Florbetapir (18F) in Daily Clinical Setting: Based on the Post-Marketing Surveillance Study].
2019
·
Tomomi Nakamura
, Taka Matsumura
, et al.
·
PubMed
·
1
Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain
2014
·
Keiichiro Imanaka
, Yushin Tominaga
, et al.
·
Current Medical Research and Opinion
·
1
PDF
Evaluation of Efficacy and Safety of Paliperidone Palmitate with Schizophrenia: Subpopulation Analysis of Japanese Patients in the 13-Week, Double-Blind, Randomized, Placebo-Controlled Asian Study
2013
·
Akihide Wakamatsu
, Nagahide Takahashi
, et al.
·
Progress in medicine
·
1
Show more works
View as search
Works count:
15
Citation count:
248
H-index:
8
I10-index:
7
Year
Topic
Type